Calumet (NASDAQ:CLMT) -2.8% in Tuesday's trading as TD Cowen downgrades shares to Hold from Buy with a $16 price target, cut ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...

Oliver Chen, TD Cowen senior retail analyst, joins 'Fast Money' to talk what to expect out of Target results tomorrow.

TD Cowen analyst John Kernan lowered the firm’s price target on On Holding (ONON) to $64 from $66 and keeps a Buy rating on the shares. The ...

Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports.

AbbVie Inc. ( NYSE: ABBV) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET Scott T. Reents - Executive Vice President and Chief Financial Officer Jeffrey R. Stewart - Executive ...

Microsoft Corp. has canceled some leases for U.S. data center capacity, according to TD Cowen, raising broader concerns over ...

The Washington-based software giant has canceled leases in the US totaling “a couple of hundred megawatts,” or about two huge data centers, according to a report from TD Cowen analysts ...

TD Cowen upgraded Mytheresa (MYTE) to Buy from Hold with a price target of $14, up from $13, after meeting with management. The firm now has ...

Mit Blick auf den KI-Nachfrage-Ausblick lässt ein Bericht der Investmentbank TD Cowen aufhorchen: Microsoft hat demnach ...

Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...